Systemic and intracranial activity of antibody-drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis.
INTRODUCTION Brain metastases (BM) remain a major clinical challenge in patients with non-small cell lung cancer (NSCLC). Although antibody-drug conjugates (ADCs) have emerged as important treatment options for advanced NSCLC, their efficacy in patients with BM remains uncertain because of concerns regarding blood-brai...